Rifaximin 40 mg Soluble Solid Dispersion Immediate Release Tablets (SSD-40IR) clinical trials

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RIFAXIMIN SOLUBLE SOLID DISPERSION (SSD) TABLETS FOR THE DELAY OF ENCEPHALOPATHY DECOMPENSATION IN CIRRHOSIS (RED-C)

This study is looking at a new form of a drug called Rifaximin to see if it can help people with liver disease (cirrhosis) avoid serious brain problems (hepatic encephalopathy) that need hospital care. It compares the new drug to a dummy pill.